Dako HercepTest™ - P980018/S010
The medical device was FDA approved on October 20, 2010. HercepTest™ is a lab test that is used to quantify the HER2 protein being produced by cancer cells.
It was previously used to detect protein made by breast cancer cells and now has the indication to test for spreading stomach cancer (cancer that has gone metastatic).
The test along with other lab tests will determine candidates for Herceptin® therapy.
No comments:
Post a Comment